[
  {
    "The following situations are generally inappropriate for VTE/Thrombophilia eConsult [PLEASE PLACE AN IN-PERSON REFERRAL INSTEAD]": [
      "Recurrent VTE",
      "Cancer-associated thrombosis",
      "Pregnancy",
      "Autoimmune disease",
      "History of both arterial and venous thrombosis",
      "Presence of an IVC Filter"
    ]
  },
  {
    "My Clinical Question (condition: VTE/Thrombophilia)": "***"
  },
  {
    "My most current assessment of this problem can be found in the note dated": "{Today/***}"
  },
  {
    "In your clinical question, or current note, please include information on": {
      "Assessments": {
        "Required": [
          {
            "Risk factors for VTE present (make sure to document all: family history, weight, prior VTE, lower extremity exam, updated medication list, age-appropriate cancer screening)": "***"
          },
          {
            "Imaging or radiology report of VTE": "***"
          }
        ],
        "Optional": []
      },
      "Diagnostics": {
        "Required": [
          {
            "CBC with diff (on two consecutive checks at least one week apart)": "***"
          },
          {
            "CMP": "***"
          },
          {
            "Ferritin": "***"
          }
        ],
        "Optional": []
      },
      "Clinical Pearls": [
        {
          "Therapy guideline:  https://depts.washington.edu/anticoag/home/": [
            {
              "Superficial thrombophlebitis – prophylactic dose for 6 weeks if high-risk": "***"
            },
            {
              "Line-associated DVT – 3 months or until line out, whichever longer": "***"
            },
            {
              "Distal DVT – 3 months (unless anticoagulation-averse, asymptomatic, low-risk, then serial US)": "***"
            },
            {
              "Proximal DVT – 3-6 months at the minimum": "***"
            }
          ]
        },
        {
          "In most circumstances, we do not perform thrombophilia screening or specific management for patients > 45 years old": "***"
        },
        {
          "Avoid testing antithrombin, protein C, protein S during acute thrombosis or active anticoagulation": "***"
        },
        {
          "Uncommon causes of hypercoagulability (especially if presenting with splanchnic vein thrombosis or cerebral venous sinus thrombosis) include JAK2 mutation and paroxysmal nocturnal hemoglobinuria": "***"
        },
        {
          "Consider screening for proteinuria for nephrotic syndrome": "***"
        },
        {
          "Consider testing for antiphospholipid syndrome": "***"
        },
        {
          "We generally recommend that incidental PE or subsegmental PE be treated as a standard PE": "***"
        },
        {
          "For provoked VTE due to a surgical risk factor, we recommend finite anticoagulation due to low risk of recurrence": "***"
        },
        {
          "Unprovoked VTE are generally treated indefinitely assuming the bleeding risk is low although should be discussed with hematology further": "***"
        },
        {
          "The superficial femoral vein is a deep vein!": "***"
        }
      ]
    }
  }
]
